Clinical End Points in Laser Therapy: Warning Signs and Therapeutic Responses
If you don’t know clinical end points in laser therapy, you will have a greater likelihood of severe or long-lasting side effects, says Dr. Fernanda Sakamoto, assistant professor of dermatology at Harvard Medical School. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Sakamoto, who explained how clinical end points can give dermatolo …
If you don’t know clinical end points in laser therapy, you will have a greater likelihood of severe or long-lasting side effects, says Dr. Fernanda Sakamoto, assistant professor of dermatology at Harvard Medical School. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Sakamoto, who explained how clinical end points can give dermatolo … Continue reading "Clinical End Points in Laser Therapy: Warning Signs and Therapeutic Responses"
Which of the following is the most likely diagnosis?
A. Erythema multiforme
B. Annular urticaria
C. Secondary syphilis
D. Fixed drug eruption
E. Polymorphous light eruption
To find out the correct answer and read the explanation, click here. … 
HealthCentral recently highlighted new research out of Harvard Medical School on the role of Staphylococcus aureus (S. aureus) in itch. Researchers found S. aureus can trigger itch in mice and human cells through communication with sensory neurons.
For an expert’s take, I reached out to Gil Yosipovitch, MD, professor, Stiefel Chair of Medical Dermatology and director of the Miami Itch Center … 
Metronidazole is a nitroimidazole with antiprotozoal, antibacterial, and anti-inflammatory properties and is available in oral and topical formulations. The diverse mechanisms of action of metronidazole have expanded its utility across various dermatologic conditions. Topical metronidazole is well tolerated and has demonstrated improvements in inflammatory papules and pustules of rosacea. We conti … 
Participating in dermatology research can be a fulfilling part of a dermatologist’s career. So how can a dermatologist start participating in clinical trials? Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Leon Kircik, clinical professor of dermatology at Icahn School of Medicine. Watch as Dr. Kircik shares the three pillars of a cl …